Categories: Market Research

Cold Pain Therapy Market Size and Forecast 2024-2033|Unexo Lifesciences Pvt. Ltd., Össur Corporate, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Pfizer Inc

Sick Woman Covered With a Blanket Lying in Bed With High Fever and a Flu, Resting at Living Room. She Is Exhausted and Suffering From Flu. Sick Woman With Runny Nose Lying in Bed. Girl Suffering From Cold Lying in Bed With Tissue Blowing Her Nose While Sitting on the Sofa

Overview and Scope

Cold pain therapy refers to a therapy used to reduce inflammation and swelling effectively. The primary purpose is to treat injuries that cause pain by lowering the temperature at the surface of the area affected by the pain. It helps to slow the rate of tissue damage around a joint or tendon.

Sizing and Forecast

The cold pain therapy market size has grown strongly in recent years. It will grow from $1.66 billion in 2023 to $1.79 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rise in sports injuries, chronic pain management, post-surgery recovery, orthopedic applications, fitness and rehabilitation.

The cold pain therapy market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to professional endorsements, innovative marketing strategies, digital health adoption, supportive regulatory environment, geriatric population demand, rise in orthopedic conditions.. Major trends in the forecast period include increased sports and fitness focus, shift towards non-pharmacological methods, at-home treatment preference.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report

Segmentation & Regional Insights

The cold pain therapy market covered in this report is segmented –

1) By Product: OTC Products, Prescription Products

2) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, E- Pharmacies

3) By Application: Musculoskeletal Disorders, Post-operative Therapy, Sports Injuries, Post-trauma Therapy

North America was the largest region in the cold pain therapy market share in 2023. The regions covered in the cold pain therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8358&type=smp

Major Driver Impacting Market Growth

The increased importance of gym activities is significantly contributing to the growth of the cold pain therapy market. Gym activities are increasing due to the need to improve brain health, help manage weight, lower the risk of disease, strengthen bones and muscles, and improve the ability to do everyday tasks. Cold pain therapy products alleviate pain caused by musculoskeletal injuries that occur in gym activities. For instance, in March 2022, according to a report by the Australia Bureau of Statistics, an agency of the Australian Government responsible for statistical collection and analysis, 73.4% of adults aged between 18 and 64 in Australia undertook 150 minutes or more of physical activity regularly, thereby increasing the potential for muscle and tendon injuries. Therefore, the increasing importance of gym activities will drive the cold pain therapy market.

Key Industry Players

Major companies operating in the cold pain therapy market report are Unexo Lifesciences Pvt. Ltd., Össur Corporate, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Pfizer Inc., Sanofi S.A., Rohto Pharmaceutical Co. Ltd., 3M Company, Cardinal Health Inc., Compass Health Brands, Breg Inc., Medline Industries LP, Performance Health Supply Inc., Romsons Group of Industries, Beiersdorf AG, DJO Global Inc., Gilead Sciences Inc., Astellas Pharma Inc., AstraZeneca plc, Novo Nordisk A/S, Polar Products Inc., The Bristol-Myers Squibb Company, Mueller Sports Medicine Inc., Eli Lilly and Company, Bruder Healthcare Company LLC, ThermoTek Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Medtronic plc, Performance Health LLC

The cold pain therapy market report table of contents includes:

1. Executive Summary

2. Cold Pain Therapy Market Characteristics

3. Cold Pain Therapy Market Trends And Strategies

4. Cold Pain Therapy Market – Macro Economic Scenario

5. Global Cold Pain Therapy Market Size and Growth

26. South America Cold Pain Therapy Market

27. Brazil Cold Pain Therapy Market

28. Middle East Cold Pain Therapy Market

29. Africa Cold Pain Therapy Market

30. Cold Pain Therapy Market Competitive Landscape And Company Profiles

Top Major Players: